Harvey Price, who is autistic and has Prader-Willi syndrome, accidentally took two of mum Katie Price's CBD gummies and they ...

Katie Price has revealed she plans to start giving her son Harvey CBD gummies regularly, after he accidentally took a couple ...

KATIE Price has revealed that her son Harvey has lost 1.5 stone after starting fat jabs. She also revealed how he smashed ...

We see them on the big screen, dazzling red carpets, and dominating headlines. But what happens when the cameras stop rolling ...

Go inside Katie Price's turbulent career. From her rise as Jordan and building a business empire to her shocking legal ...

Katie Price has revealed that she's decided to start giving her son Harvey CBD gummies, after he accidentally took two and ...

Treatment with intranasal carbetocin was not associated with a statistically significant improvement in hyperphagia compared with placebo. Topline results were announced from a phase 3 trial ...

SGLT2 inhibitors significantly improved glycaemic control and reduced the albumin-to-creatinine ratio without affecting body weight in patients with Prader-Willi syndrome and type 2 diabetes (T2D); ...

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD) released topline results on Wednesday from its Phase 3 COMPASS PWS trial evaluating the efficacy and safety of intranasal carbetocin (ACP-101) in patients ...

(RTTNews) - Tonix Pharmaceuticals Holding Corp. (TNXP) on Monday said it plans to start a Phase 2 study of TNX-2900 for the treatment of Prader-Willi syndrome, a genetic disorder that affects multiple ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to 17.5 years) with Prader-Willi Syndrome under a cleared IND TNX-2900 ...